Elevated Galectin-3 Levels in the Serum of Patients With Alzheimer's Disease. - Wikidata - wikimedia - TriplyDB

Elevated Galectin-3 Levels in the Serum of Patients With Alzheimer's Disease.

Elevated Galectin-3 Levels in the Serum of Patients With Alzheimer's Disease.

http://www.wikidata.org/entity/Q42256539

about

Vesicular Galectin-3 levels decrease with donor age and contribute to the reduced osteo-inductive potential of human plasma derived extracellular vesicles.Galectin-3 Negatively Regulates Hippocampus-Dependent Memory Formation through Inhibition of Integrin Signaling and Galectin-3 Phosphorylation Desipramine decreases expression of human and murine indoleamine-2,3-dioxygenases.Galectin-3 induces cell migration via a calcium-sensitive MAPK/ERK1/2 pathway.Increases of Galectin-1 and its S-nitrosylated form in the Brain Tissues of Scrapie-Infected Rodent Models and Human Prion Diseases.Depression in type 1 diabetes was associated with high levels of circulating galectin-3.Galectin-3 and incident cognitive impairment in REGARDS, a cohort of blacks and whites.IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis.Investigation of Gal-3 Expression Pattern in Serum and Cerebrospinal Fluid of Patients Suffering From Neurodegenerative Disorders Galectin-3-Mediated Glial Crosstalk Drives Oligodendrocyte Differentiation and (Re)myelination

P2860

Q36601648-0444CE44-B507-405B-8BCE-D6E251D11034 Q38661342-7EAD2237-C5B1-467A-AEA0-F038B3984EDB Q38954921-00769D65-6C7B-4D0A-B00E-CB5C4326DC28 Q40084619-492778BF-2C21-48C1-8F74-4E9D2CEB713A Q40664403-37F8CB68-A5C4-4C0B-A542-387618E50D89 Q55302722-950BF806-E388-4D54-993F-6A840B39F638 Q55383284-8C06E4AD-637C-4068-BB72-69AE5D029834 Q55514878-667895E8-0A19-42E4-8D4F-0DF213A6C349 Q57000023-EA65A590-4E71-4ECA-A116-A1FBF79D0C73 Q57157917-24B616DE-C3F9-49DB-90FE-534E36C54231

P2860

Elevated Galectin-3 Levels in the Serum of Patients With Alzheimer's Disease.

http://www.wikidata.org/entity/Q42256539

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Elevated Galectin-3 Levels in the Serum of Patients With Alzheimer's Disease.

@en

Elevated Galectin-3 Levels in the Serum of Patients With Alzheimer's Disease.

@nl

type

label

Elevated Galectin-3 Levels in the Serum of Patients With Alzheimer's Disease.

@en

Elevated Galectin-3 Levels in the Serum of Patients With Alzheimer's Disease.

@nl

prefLabel

Elevated Galectin-3 Levels in the Serum of Patients With Alzheimer's Disease.

@en

Elevated Galectin-3 Levels in the Serum of Patients With Alzheimer's Disease.

@nl

P1433

Q42256539-C5D79CD5-CD01-4768-A9A7-9499DB92A92F

P1476

Q42256539-06717066-5A66-4E48-ABE6-08FCD2F0513C

P2093

Q42256539-2EBE40B0-FF7F-4223-BCE6-1B24FADF21A6

Q42256539-305D7F98-FB23-4D78-9DC8-BE9673565EBF

Q42256539-3A58692B-D6C6-40C1-B8D9-52D5C736846B

Q42256539-4DE6E5E5-96AF-40D8-83BD-DF1ECFD58D64

Q42256539-FA74A8D5-F9F1-4DFA-B1D3-177246CF2B20

P2860

Q42256539-06A4B16B-E58F-4425-AB5C-2167C550CD3F

Q42256539-0CB40E93-3131-4358-AB30-B4E3C95442FF

Q42256539-2DF76C00-3451-4588-8919-40C6654ED033

Q42256539-3BABB438-EAE6-4098-B57F-6485D03CFE1E

Q42256539-4A665456-CDEE-4E33-BCA1-7DA4E2057D75

Q42256539-5B401583-77E0-4613-8BFA-6C162EB7C81C

Q42256539-6C7706FC-0D63-48AF-A9B2-788561A0DEAC

Q42256539-6D936489-58D1-49B8-833B-DC17EECF196D

Q42256539-6E4E6763-1482-42DE-8757-7970A02254C1

Q42256539-71295FFD-0C48-425B-8DE6-FC0BC0FA8572

P304

Q42256539-C59A267E-735B-4B02-A653-541D89B6526C

P31

Q42256539-7C1362BB-2551-4290-B98C-090C39812AA9

P356

Q42256539-C92DFC45-A0C9-4677-B0AE-09F34CC5561C

P407

Q42256539-F8AAADE2-8284-4E87-A833-D1F02E7F883F

P433

Q42256539-965C9718-22E0-4DE8-AB7C-11A344CB72AE

P478

Q42256539-041A06C7-1999-4562-BB2F-D749723123C0

P577

Q42256539-7485EB99-7E64-4C35-A0DC-9723351CD9A1

P698

Q42256539-5A7CA39C-60D6-4179-84F7-09FD37347473

P921

Q42256539-D12FF3D4-AD51-44E2-BD9A-17967DA4E638

P356

1533317513495107

P1433

American Journal of Alzheimer's Disease & Other Dementias

P1476

Elevated Galectin-3 Levels in the Serum of Patients With Alzheimer's Disease.

@en

P2093

Faliang Lin

http://www.w3.org/2001/XMLSchema#string

Shouwei Yue

http://www.w3.org/2001/XMLSchema#string

Shuping Zhang

http://www.w3.org/2001/XMLSchema#string

Wenzheng Chu

http://www.w3.org/2001/XMLSchema#string

Xuexin Wang

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Mild cognitive impairment: clinical characterization and outcome

Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocation

The roles of Galectin-3 in autoimmunity and tumor progression

Galectins: structure, function and therapeutic potential

The blood-brain barrier in health and chronic neurodegenerative disorders

Translating cell biology into therapeutic advances in Alzheimer's disease.

Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response

Galectin-3 is a candidate biomarker for amyotrophic lateral sclerosis: discovery by a proteomics approach.

P304

729-732

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1533317513495107

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23823143

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease